1.. Introduction {#S1}
================

Both statistical and process-based infectious disease forecasting approaches rely heavily on disease surveillance. Observations of past and present disease activity are used to optimize model systems prior to generating a forecast ([@R34]), and this optimization is critical for producing accurate and calibrated predictions. From this vantage, an idealized surveillance system for vector-borne disease would include frequent, high-quality observations of disease dynamics in both the human and vector populations. Measurements would include prevalence and incidence, as well as immune status, in the human population, and vector infection rates, longevity, and abundance for the vector population. However, current vector-borne disease surveillance systems are frequently limited to passive surveillance of human incidence ([@R6]). These incomplete observations reduce the accuracy of vector-borne disease forecasting ([@R38]).

Traditionally, surveillance of *Aedes* mosquitoes has consisted primarily of monitoring for the presence of mosquito larvae and pupae inside households ([@R29]). However, these indicators have not been consistently associated with adult mosquito density or of disease incidence ([@R8]; [@R24]; [@R7]; [@R36]; [@R16]). In a recent systematic review, [@R7] found only four studies reporting positive correlations between larval and adult *Aedes* indices and dengue transmission. More recently, measures of adult vector abundance and infection rates have been incorporated into disease surveillance systems and used to improve understanding of the spatiotemporal risk of disease transmission ([@R17]; [@R28]; [@R30]; [@R10]; [@R37]). Several studies have incorporated mosquito surveillance data into early warning or forecast systems for disease outbreaks ([@R32]; [@R12]; [@R35]; [@R19]; [@R11]; [@R18]). However, few have sought to quantify the value of surveillance data in predicting future disease risk. [@R19] quantified the value of mosquito abundance and infection rates at different temporal and spatial scales as predictors in regression models of West Nile Virus. [@R11] used environmental predictors along with mosquito infection rates to forecast West Nile Virus and noted an improvement in forecast once mosquito data became available, but did not compare forecasts with and without these data.

Another type of relevant data that may soon become more widely available is the susceptibility of a population to a given disease. The transmission dynamics of vector-borne diseases are known to be shaped in part by a population's previous exposure to the pathogen ([@R31]; [@R39]; [@R5]; [@R14]; [@R22]). Currently, such information for vector-borne disease has generally been limited to seroprevalence surveys conducted at isolated research sites ([@R15]). However, with the rapid improvement and availability of diagnostic tests, such testing may soon become feasible ([@R4]; [@R13]). For example, a recent study suggested that routine seroprevalence surveys could be implemented in a network of major cities across Brazil to improve dengue forecasting capabilities ([@R25]).

The value of incorporating additional observations into a model-inference forecast system can be explicitly assessed using a synthetic testing framework. This strategy assumes perfect knowledge of the modeled system, which is considered to be the "truth". Synthetic observations are then drawn from this "truth" and assimilated by the model-filter system in order to optimize the model and predict future incidence (i.e. the future truth).

In numerical weather prediction and related fields, there is a large body of work built around the framework of synthetic testing of observations (e.g., [@R40]; [@R41]; [@R2]; [@R21]; [@R3]). Carefully designed experiments, sometimes referred to as Observing System Simulation Experiments (OSSE), have allowed researchers and government agencies to evaluate the effects of proposed observation systems on weather predictions. Such experiments are critical for motivating and justifying the deployment of costly new observation platforms such as satellite-mounted temperature sounders ([@R2]).

Here, we apply a synthetic testing framework to an infectious disease system and explore the effects of data availability and quality on vector-borne disease forecast accuracy using a process-based model. Specifically, we compared forecast accuracy for different levels of data uncertainty, and quantified the changes in accuracy when simulated vector surveillance data were additionally assimilated into a model-inference forecasting system. We also examined the effects of reducing uncertainty in the prior distribution of human susceptibility. Finally, we tested whether reducing uncertainty of some model parameters affects forecasting accuracy. The described synthetic testing approach can be used to inform decision-making when designing or adjusting disease surveillance systems.

2.. Methods {#S2}
===========

2.1.. Disease transmission model {#S3}
--------------------------------

In this study, we use a Susceptible-Exposed-Infectious-Recovered (SEIR) model structure for the human population, coupled with a Susceptible-Exposed-Infectious (SEI) model structure for the vector population ([Supplemental Fig. 1](#SD1){ref-type="supplementary-material"}). Adaptations of this model form have been used to simulate a number of mosquito-borne diseases, including dengue ([@R26]), Zika ([@R27]; [@R20]), Chikungunya ([@R26]; [@R27]), and Malaria ([@R9]). Here, we use the model to simulate dengue fever, transmitted by *Aedes* mosquitoes.

The model equations are as follows: $$\frac{dS_{H}}{dt} = - \text{B}_{H}S_{H}I_{M}$$ $$\frac{dE_{H}}{dt} = \text{B}_{H}S_{H}I_{M} - \alpha_{H}E_{H}$$ $$\frac{dI_{H}}{dt} = \alpha_{H}E_{H} - \gamma I_{H}$$ $$\frac{dR_{H}}{dt} = \gamma I_{H}$$ $$\frac{dS_{M}}{dt} = \phi - \text{B}_{M}S_{M}\frac{I_{H}}{N_{H}} - \phi S_{M}$$ $$\frac{dE_{M}}{dt} = \text{B}_{M}S_{M}\frac{I_{H}}{N_{H}} - \left( {\phi + \alpha_{M}} \right)E_{M}$$ $$\frac{dI_{M}}{dt} = \alpha_{M}E_{M} - \phi I_{M}$$

*S~H~, E~H~, I~H~*, *R~H~* and *N~H~* refer to the number of susceptible, exposed, infectious, recovered, and total humans, respectively. *S~M~, E~M~* and *I~M~* are the proportion of the mosquito population that are susceptible, exposed or infectious, respectively. The model parameters are defined in [Table 1](#T1){ref-type="table"}. The model is run deterministically.

Observed human incidence is given by the number of newly infected humans*, E~H~*, times the fraction of infections reported, *p*: $$Obs_{H} = p\alpha_{H}E_{H}$$

2.2.. Ensemble adjustment Kalman Filter (EAKF) {#S4}
----------------------------------------------

The above model of disease transmission was coupled with the EAKF, a data assimilation method ([@R1]) that uses observations to iteratively optimize model parameters and state variables over the course of a disease outbreak in a prediction-update cycle. Here, the model-filter system employs an ensemble of 300 simulation replicates with parameters and state variables randomly initialized using values drawn from the prior distributions indicated in [Table 1](#T1){ref-type="table"}. The prediction step uses the dengue transmission model to propagate each ensemble member forward in time until one or more observations are available. In the update step, the EAKF algorithm (see [@R1] for full algorithm details) uses Bayes' rule to assimilate new observations by adjusting the ensemble members such that their mean and variance match the posterior mean and variance, given a prescribed observational error variance. This error is a function of the magnitude of disease incidence, as described below in [Eq. (9)](#FD9){ref-type="disp-formula"}.

Following each update step, the model-filter system is integrated through time to the next observation and the update is repeated. A forecast is generated when the ensemble of updated parameter and state variable estimates---the posterior---is propagated forward through the remainder of the season without further updating, thus producing an ensemble of future disease incidence trajectories. The central idea is that the ensemble of simulations, having been iteratively optimized with observations during the prior weeks is better aligned to generate a credible forecast of future incidence. Here, the trajectories are used to provide forecasts of the following target metrics:

1.  The timing of the outbreak peak (peak week)

2.  Peak observed incidence

3.  Total observed incidence

4.  Number of cases reported in the next 1 through 4 weeks

2.3.. Experimental setup {#S5}
------------------------

We used the disease transmission model to generate 20 disease outbreaks of varying magnitudes and 1-year duration ([Supplemental Fig. 2](#SD1){ref-type="supplementary-material"}). Each of these model realizations provides a time series of 'true' values for all parameters and state variables at each time-step. We then used the synthetic truths to generate observations by adding noise to the true values of the observed variables; observations were drawn from a normal distribution with mean equal to the synthetic truth and variance as described below. We used a model time-step of one day, and the sampling resolution of observations was set to every seven days.

We modeled observational error variance as a function of the magnitude of disease incidence, using the formula ([@R33]): $$OEV_{k} = a + \frac{\left( {\sum_{j = k - 3}^{k - 1}\frac{X_{j}}{3}} \right)^{2}}{b}$$

Where *X*~j~ represents the observation at time j (*Obs~H~* for the number of infected humans and *I~M~* for the fraction of infectious mosquitoes), *a* represents a constant baseline noise, and the fractional component represents a magnitude-dependent error. We set the values of *a* and *b* to 1000 and 5, respectively, for observations of *Obs~H~.* Observations of *I~M~* used values of 10^−5^ and 5, respectively, for *a* and *b.* Adjusting for modeled population size, *a* represents a standard deviation of one order of magnitude higher for mosquito observations compared to human observations, reflecting greater uncertainty in mosquito observations. Model sensitivity to these parameter settings was tested by altering the values *a* and *b* (see below).

For each synthetic truth, we generated ten time series of observations by taking ten random draws around the truth ([Fig. 1](#F1){ref-type="fig"}). We then used the model-filter system to estimate parameters and forecast outbreak characteristics for each set of 'synthetic' observations. The data assimilation process was repeated ten times for each set of observations, each time using a new set of initial conditions for the ensemble members and producing 51 weekly forecasts. For each weekly forecast, the EAKF was sequentially applied to observations from week 1 through *k*, and then the optimized model was used to forecast the remainder of the year from weeks k+1 through 52. The result was 100 sets of parameter estimates and forecasts for each synthetic truth. When comparing the performance of the model-filter system, the primary measure of accuracy for each test case is the mean absolute error (MAE) of the seven forecast targets (peak week, peak incidence, total incidence, and 1through 4-week ahead incidence) over all 2000 simulations (20 truths × 100 sets of forecasts per truth) and 51 weeks of forecasts. We also compared mean absolute relative error (MARE) for peak incidence and total incidence, to account for differences in outbreak intensity.

In addition to analyzing mean errors, we ranked the accuracy of the forecasts and posterior estimates at each forecasting week and compared the accuracy of the mean rankings. We performed the Friedman test followed by a Nemenyi test to assess statistically significant differences between mean forecast rankings. The Friedman test is a nonparametric test of differences in the ranking of each trial that assesses whether any of the trial conditions consistently outperformed the other conditions. The Nemenyi test is a post-hoc assessment of statistically significant differences in rankings between each pair of trial conditions.

### 2.3.1.. Quality of observations {#S6}

We investigated the effect of data quality by varying the magnitude of error added to the truth when generating synthetic observations. This was achieved by altering parameters *a* and *b* in [Eq. (9)](#FD9){ref-type="disp-formula"}. We tested three values of *b* for synthetic observations of *Obs~H~*: 5, 10 and 20 ([Fig. 1](#F1){ref-type="fig"}). For synthetic observations of *I~M~*, we compared a low-variance case with *a* = 10^−6^ and *b* = 20, and a high-variance case with *a=* 10^−5^ and *b=* 5.

### 2.3.2.. Number of observational data streams {#S7}

Dengue surveillance systems generally measure disease incidence in humans; however, mosquito surveillance can provide information about the circulating virus. We investigated the effect of assimilating observations of mosquito infection rates by comparing forecasts in which the model-filter system incorporates observations of human incidence, *Obs*~H~ alone, to forecasts using observations of *I~M~* in addition to *Obs~H~.*

To incorporate observations of *I~M~,* the update step of the EAKF is performed twice in order to sequentially adjust the ensemble in response to the two observed variables. Observational noise is set to the default parameters for *a* and *b* (listed above).

### 2.3.3.. Initial susceptibility {#S8}

The proportion of a population that is susceptible to a disease at the beginning of an outbreak plays an important role in shaping disease transmission dynamics. We tested whether knowledge of population susceptibility prior to an outbreak would improve model performance. This was achieved by altering the prior distribution of human susceptibility used to initialize the model-filter system. We first tested a naïve case, allowing susceptibility to range from 0 to 95% of the total population. We then constrained initial susceptibility by restricting the prior distribution to a certain percentage around the initial value of the synthetic truth. We tested 4 levels of restriction, representing varying quality estimates of population susceptibility: 50%, 25% and 10% of the full range, centered around the truth, and a fourth case where each ensemble member was initialized with the true value of initial susceptibility. These simulations used two observational data streams (*Obs~H~* and *I~M~).*

### 2.3.4.. Prior distribution of parameters {#S9}

We tested the effect of narrowing the prior distributions for each of the model parameters. For each of the parameters, we conducted a set of simulations where the prior distribution for that parameter was restricted to 25% of the full range listed in [Table 1](#T1){ref-type="table"}, centered around the true value used to the generate the synthetic outbreak being modelled.

3.. Results {#S10}
===========

3.1.. Quality of observations {#S11}
-----------------------------

Forecast error decreased as the observational error for human incidence decreased ([Table 2](#T2){ref-type="table"}). Pairwise differences in forecast rankings were statistically significant (p \< 0.001), with the exception of H~high~ vs H~low~ in forecasts of human incidence 3- and 4-weeks ahead ([Supplemental File 1](#SD1){ref-type="supplementary-material"}). Forecast MAE and MARE decreased with observational error of mosquito incidence for all metrics except total incidence ([Table 2](#T2){ref-type="table"}). However, mean forecast rankings of peak incidence and incidence 4-weeks ahead were not significantly different between high and low mosquito observational error ([Table 3](#T3){ref-type="table"}). Forecast rankings followed a consistent pattern, with high-variability observations leading to the worst rankings and low-variability observations leading to best rankings ([Fig. 2](#F2){ref-type="fig"}).

3.2.. Number of observational data streams {#S12}
------------------------------------------

Forecast MAE and MARE decreased for all targets when the model-filter system incorporated observations of mosquito infection rates in addition to high-variability observations of human incidence ([Table 2](#T2){ref-type="table"}). The addition of mosquito observations consistently produced better ranking forecasts ([Fig. 2](#F2){ref-type="fig"}), which in turn led to significant improvement in mean rankings for most forecast metrics ([Table 3](#T3){ref-type="table"}; [Supplemental File 1](#SD1){ref-type="supplementary-material"}). For the levels of observational error we tested, we observed a larger improvement in peak week and 1- through 4- week ahead forecast accuracy from adding mosquito observations than from decreasing the error of human observations ([Table 2](#T2){ref-type="table"}). The same was true for the mean ranking of peak week, peak incidence and 4-week ahead forecasts; for the other metrics, incorporating mosquito observations and improving human incidence observations led to similar mean rankings, i.e. not statistically significant different ([Table 3](#T3){ref-type="table"}).

3.3.. Initial susceptibility {#S13}
----------------------------

Constraint of the range of initial human susceptibility increased forecast MAE for all metrics except peak incidence ([Table 4](#T4){ref-type="table"}). However, constraint of initial susceptibility to 25% of the full range provided a small advantage in Friedman rankings for all forecast metrics except total incidence ([Table 5](#T5){ref-type="table"}); initial ranges lower than 25% did not provide additional improvement. Conversely, the 0% range test case had the largest MAE in 1- through 4- week ahead forecasts, despite being tied for the best mean rankings.

The discrepancy between MAE and ranking is explained in [Fig. 3](#F3){ref-type="fig"} and [Supplemental Fig. 3](#SD1){ref-type="supplementary-material"}, which show that while forecasts using the full range of initial susceptibility frequently produced the best-ranking forecast, they also had many of the worst ranking forecasts. Providing a narrower initial prior for susceptibility at 25% of the full range (or less than 25%, for the 1- through 4-week ahead metrics) produced more conservative, mid-ranking forecasts and an overall advantage in mean rankings. These contrasting findings indicate that while constraint of initial susceptibility increased forecast MAE on average, it led to greater consistency in forecast quality.

3.4.. Prior distribution of parameters {#S14}
--------------------------------------

The effect of narrowing the prior distribution of model parameters varied by target metric and parameter ([Tables 6](#T6){ref-type="table"} and [7](#T7){ref-type="table"}). Narrowing prior estimates of *p*, the percentage of infectious cases reported led to decreased MAE and MARE in all forecast metrics ([Table 6](#T6){ref-type="table"}), and the top Friedman ranking for the seasonal forecast metrics ([Table 7](#T7){ref-type="table"}). Forecasts of peak week were also slightly but significantly improved by constraining *αM*, *φ* and B*~M~*. Forecasts of peak and total incidence were degraded when parameters other than *p* were constrained. Forecasts of one- to four-week ahead incidence were improved by narrower prior estimates for all parameters except *α~M~* and *α~H~* ([Table 7](#T7){ref-type="table"}). Constraining B*~H~* led to con-flicting results; this trial had the highest MAE and MARE for all metrics ([Table 6](#T6){ref-type="table"}) and the worst mean ranking for seasonal forecast metrics, but had the best ranking for 1- to 4-week ahead incidence ([Table 7](#T7){ref-type="table"}). The 1- to 4-week ahead forecasts from this trial were most frequently the best-ranking forecast ([Fig. 4](#F4){ref-type="fig"}), but were also prone to large errors.

4.. Discussion and conclusion {#S15}
=============================

The approach presented here demonstrates how a model-inference forecasting framework can be used to draw conclusions regarding the benefits of acquiring specific types of information. Policy makers designing a disease surveillance system or considering whether to improve existing systems can test the expected impact of each type of data on forecasting accuracy, thus facilitating an informed assessment of the costs and benefits of the proposed sample.

In this idealized setting, we have shown that improvements in observational data streams can improve the ability to forecast infectious disease outbreaks. While the magnitudes of observed effects are dependent on the specifics of the observations being tested, we demonstrate the following general effects:

-   Forecasts improve as observational error decreases.

-   Inclusion of observations of vector infection rates provided a large improvement in predictive accuracy over human observations alone.

-   Reducing uncertainty in model parameter values can improve forecast skill, particularly for 1- to 4-week ahead targets.

-   Obtaining a more accurate estimate of the percentage of human cases reported presents an opportunity to make large gains in forecast accuracy.

Interestingly, reducing uncertainty in initial human population susceptibility did not clearly improve forecast accuracy. This may indicate that the model-filter system performed better when individual ensemble members were allowed to sample from a broader state-space. A similar effect was noted by our group during forecast of the 2014 West African Ebola outbreak (not published). Likewise, [@R23] found that estimated susceptibility was not selected for inclusion in a statistical forecasting model of Dengue hemorrhagic fever in Thailand. As the sampling required to establish population susceptibility would be quite expensive, this finding suggests that for current forecasting systems, such efforts may be unwarranted.

While we found that the inclusion of vector infection rates led to improvements in forecast accuracy, we note that there are many logistical and political challenges in establishing an effective vector surveillance system, as recently reviewed in Fournet et al. ([@R17]). In quantifying the improvements that could be gained by such data, policy makers can better assess whether the benefits outweigh these challenges.

The study has some limitations. We assume the model provides a perfect representation of disease transmission dynamics; clearly, this assumption is flawed, as the model, which greatly simplifies disease transmission dynamics, is highly mis-specified. For instance, we neglect the effects of seasonality, the interactions between dengue serotypes, and heterogeneous mixing of model populations. The dynamics of vector-borne disease transmission can vary widely depending on the disease in question, as well as local factors such as climate and disease endemicity. For example, in some locations, a rainfall or temperature driven model would be more appropriate than the form we have used here. We therefore do not generalize our conclusions for all locations or diseases. This analysis presents a simple framework for determining the relative value of different types of information in a disease forecasting system. In practice, operational use of this approach would leverage actual observations of human incidence and vector surveillance. The framework can also be adapted to other, more sophisticated disease systems and forecasting models of disease transmission.
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![Box plots of high, medium and low variance observations of human incidence for one synthetic truth.\
The modeled "truth" is shown in pink. The observations drawn from this "truth" fall within the range denoted by the box and whiskers; the boxes indicate 25th and 75th percentile values, the dashed whiskers extend to the most extreme observations, apart from outliers, which are shown as red crosses. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).](nihms-1578443-f0001){#F1}

![Heatmap of forecast ranking for each target metric when varying the quality of observations and number of observational streams.\
Dark green indicates a small number of forecasts whereas dark yellow indicates a large number of forecasts. Tied ranks were assigned the minimum rank value. On the x-axis, H refers to human observations and M refers to mosquito observations. The subscripts *H, M,* and *L* refer to high, medium, and low variance, respectively.](nihms-1578443-f0002){#F2}

![Heatmap of forecast ranking for each target metric when varying initial human susceptibility.\
Dark green indicates a small number of forecasts whereas dark yellow indicates a large number of forecasts. Tied ranks were assigned the minimum rank value.](nihms-1578443-f0003){#F3}

![Heatmap of forecast ranking for each target metric for test cases with narrowed prior distribution of parameters\
Dark green indicates a small number of forecasts while dark yellow indicates a large number of forecasts. Tied ranks were assigned the minimum rank value.](nihms-1578443-f0004){#F4}

###### 

Model parameters and state variables.

             Parameter / State variable                      Units      Distribution of initial values
  ---------- ----------------------------------------------- ---------- --------------------------------
  *α*~*M*~   1 / Extrinsic incubation period                 days^−1^   Uniform \[1/14,1/7\]
  *α*~*H*~   1 / Intrinsic incubation period                 days^−1^   Uniform \[1/7,1/4\]
  *γ*        1 / Human infectious period                     days^−1^   Uniform \[1/12,1/4\]
  *ϕ*        Mosquito death rate                             days^−1^   Uniform \[1/30,1/3\]
  B~*H*~     Mosquito to human transmission rate             \-         Uniform \[0,5\]
  B~*M*~     Human to mosquito transmission rate             \-         Uniform \[0,1\]
  P          Fraction of human infections reported           \-         Uniform \[0,1\]
  S~H~       Number of susceptible humans                    Humans     Uniform \[0, .95\*N\]
  E~H~       Number of exposed humans                        Humans     0
  I~H~       Number of infectious humans                     Humans     Exponential \[mean = 5\]
  R~H~       Number of recovered humans                      Humans     N~H~ -S~H~ - E~H~ - I~H~
  S~M~       Proportion of mosquitoes that are susceptible   \-         1
  E~M~       Proportion of mosquitoes that are exposed       \-         0
  I~M~       Proportion of mosquitoes that are infectious    \-         0

###### Forecast MAE for Test Cases comparing quality of observations and number of observational streams.

Mean absolute relative error is shown in parentheses for Peak Incidence and Total Incidence. X1 through X4 indicate forecasts of incidence 1 through 4 weeks into the future. H~high~,H~medium~ and H~low~ are test cases using only observations of human incidence, with high, medium and low error, respectively. H~high~,M~high~ and H~high~,M~low~ are test cases using high-variance observations of human incidence along with high and low variance observations of mosquito infection rates, respectively.

  Test case         Peak week   Peak Incidence   Total Incidence   X1     X2     X3     X4
  ----------------- ----------- ---------------- ----------------- ------ ------ ------ ------
  H~high~           3.7         5959 (.48)       43187 (0.40)      1424   1997   2605   3062
  H~medium~         3.6         5229 (.44)       37969 (0.36)      1252   1845   2483   2973
  H~low~            3.5         4699 (.41)       35748 (0.34)      1129   1735   2400   2919
  H~high~,M~high~   3.3         5166 (.46)       40588 (0.39)      1049   1594   2263   2844
  H~high~,M~low~    2.9         4880 (.43)       41686 (0.39)      845    1300   1961   2623

###### Mean Freidman ranking of forecast metrics for test cases comparing quality of observations and number of observational streams.

Values in bold font indicate the top-ranking test case for each forecast metric. More than one top ranking test case is possible if ranks are not significantly different. See [Supplemental File 1](#SD1){ref-type="supplementary-material"} for pairwise p-values of Friedman ranks.

  Test case         Peak week   Peak Incidence   Total Incidence   X1         X2         X3         X4
  ----------------- ----------- ---------------- ----------------- ---------- ---------- ---------- ----------
  H~High~           3.61        3.19             3.01              3.01       3.01       3.00       3.01
  H~medium~         3.32        3.09             3.06              3.06       3.08       3.04       3.05
  H~low~            2.91        2.95             **2.97**          **2.96**   **2.96**   2.99       3.00
  H~high~,M~high~   2.60        **2.88**         **2.97**          2.99       **2.98**   3.00       **2.97**
  H~high~,M~low~    **2.56**    **2.89**         3.00              **2.98**   **2.97**   **2.97**   **2.97**

###### Forecast MAE for test cases varying initial human susceptibility.

Mean absolute relative error is shown in parentheses for Peak Incidence and Total Incidence. ×X1 through X4 indicate forecasts of incidence 1 through 4 weeks into the future.

  Range of initial human susceptibility   Peak week   Peak incidence   Total incidence   X1     X2     X3     X4
  --------------------------------------- ----------- ---------------- ----------------- ------ ------ ------ ------
  full range (control)                    3.3         5171 (.45)       39288 (.38)       1040   1578   2262   2868
  0.5                                     3.4         5162 (.40)       45969 (.37)       1166   1741   2411   2994
  0.25                                    3.4         4810 (.38)       42559 (.36)       1106   1686   2358   2929
  0.1                                     3.5         4953 (.38)       43694 (.36)       1171   1782   2476   3046
  0                                       3.5         5108 (.39)       45468 (.37)       1210   1822   2516   3092

###### Mean Freidman ranking of forecast metrics for test cases varying initial human susceptibility.

Values in bold font indicate the top-ranking test case for each forecast metric. More than one top ranking test case is possible if ranks are not significantly different. Asterisks indicate mean rankings that are statistically significant improvements over the control case.

  Test case              Peak week    Peak Incidence   Total Incidence   X1           X2           X3           X4
  ---------------------- ------------ ---------------- ----------------- ------------ ------------ ------------ ------------
  full range (control)   2.34         3.05             2.93              3.09         3.07         3.07         3.07
  0.5                    **2.34**     3.09             3.04              3.05\*       3.06         3.08         3.09
  0.25                   **2.33\***   **2.85\***       **2.93**          2.97\*       **2.96\***   **2.95\***   **2.94\***
  0.1                    2.46         3.00\*           3.00              **2.94\***   **2.95\***   **2.95\***   **2.94\***
  0                      2.53         3.01\*           3.09              **2.94\***   **2.95\***   **2.95\***   **2.95\***

###### Forecast MAE for test cases with narrowed prior distribution of parameters.

Mean absolute relative error is shown in parentheses for Peak Incidence and Total Incidence.

  Parameterbeingconstrained   Peak week   Peak Incidence   Total Incidence   X1     X2     X3     X4
  --------------------------- ----------- ---------------- ----------------- ------ ------ ------ ------
  None (control)              3.3         5171 (.45)       39288 (.38)       1040   1578   2262   2868
  ***α~M~***                  3.2         5184 (.46)       39420 (.38)       1051   1592   2256   2829
  ***α~H~***                  3.3         5241 (.46)       39776 (.39)       1051   1605   2291   2877
  ***γ***                     3.4         6091 (.46)       43308 (.40)       1125   1590   2170   2662
  ***ϕ***                     3.3         5522 (.48)       41493 (.41)       1028   1472   2032   2577
  **B*~H~***                  3.7         6361 (.55)       46920 (.41)       1294   1926   2640   3177
  **B*~M~***                  3.3         5555 (.45)       41538 (.40)       1005   1481   2100   2678
  **p**                       3.1         4635 (.37)       34465 (.31)       970    1475   2154   2785

###### Mean Freidman ranking of forecast metrics for test cases with narrowed prior distribution of parameters.

Values in bold font indicate the top-ranking test case for each forecast metric. More than one top ranking test case is possible if ranks are not significantly different. Asterisks indicate mean rankings that are statistically significant improvements over the control case.

  Parameter being constrained   Peak week    Peak Incidence   Total Incidence   X1           X2           X3           X4
  ----------------------------- ------------ ---------------- ----------------- ------------ ------------ ------------ ------------
  None (control)                3.43         4.25             4.23              4.63         4.65         4.68         4.70
  ***α~M~***                    3.31\*       4.33             4.35              4.64         4.67         4.69         4.71
  ***α~H~***                    3.50         4.37             4.33              4.67         4.69         4.71         4.72
  ***γ***                       3.55         4.83             4.85              4.65         4.60\*       4.55\*       4.51\*
  ***ϕ***                       3.31\*       4.50             4.54              4.49         4.48\*       4.50\*       4.52\*
  **B~*H*~**                    4.06         5.14             5.21              **4.12\***   **4.10\***   **4.04\***   **3.96\***
  **B~*M*~**                    3.26\*       4.61             4.59              4.43\*       4.42\*       4.43\*       4.45\*
  **p**                         **3.07\***   **3.98\***       **3.89\***        4.38\*       4.38\*       4.40\*       4.43\*
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